Earnings History Data for BioXcel Therapeutics, Inc. (BTAI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
BioXcel Therapeutics, Inc.
BioXcel Therapeutics Inc. is a clinical stage biopharmaceutical company. It focuses on drug development which utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. The company's product portfolio include BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. BioXcel Therapeutics Inc. is based in the United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | BTAI | BioXcel Therapeutics, Inc. | 27.09 | -0.32 | -0.50 | -1.72 | BioXcel Therapeutics GAAP EPS of -$0.32 beats by $0.23, revenue of $0.21M misses by $1.12M [11/14/2024 7:03 AM] |
0.52 | -0.10 (-15.99%) |
0.62 | 0.0 (0.19%) |
0.50 - 4.89 | 719,853 | 470,000 | 15,480 | ||
| 06-08-2024 | PM | BTAI | BioXcel Therapeutics, Inc. | 38.66 | -0.21 | -0.76 | -1.83 | BioXcel Therapeutics GAAP EPS of -$0.21 beats by $0.57, revenue of $1.1M in-line [8/6/2024 7:07 AM] |
0.9601 | 0.04 (4.35%) |
1.03 | 0.11 (11.94%) |
0.89 - 7.80 | 491,486 | 400,000 | 417,038 | ||
| 09-05-2024 | PM | BTAI | BioXcel Therapeutics, Inc. | 71.86 | -0.87 | -0.68 | -1.84 | BioXcel Therapeutics GAAP EPS of -$0.87 misses by $0.12, revenue of $0.58M misses by $0.05M [5/9/2024 7:07 AM] |
2.31 | 0.19 (8.73%) |
2.26 | 0.14 (6.60%) |
1.91 - 29.56 | 615,196 | 400,000 | 27,398 | ||
| 12-03-2024 | PM | BTAI | BioXcel Therapeutics, Inc. | 91.33 | -0.76 | -0.98 | -1.95 | BioXcel Therapeutics GAAP EPS of -$0.76 beats by $0.15, revenue of $0.38M misses by $0.36M [3/12/2024 7:02 AM] |
2.76 | -0.14 (-4.83%) |
3.24 | 0.34 (11.72%) |
1.91 - 29.56 | 1,364,894 | 740,000 | 116,147 | ||
| 14-11-2023 | PM | BTAI | BioXcel Therapeutics, Inc. | 151.31 | -1.72 | -1.29 | -1.49 | BioXcel Therapeutics GAAP EPS of -$1.72 misses by $0.48, revenue of $0.34M misses by $0.29M [11/14/2023 7:15 AM] |
4.22 | -1.29 (-23.32%) |
3.53 | -1.98 (-35.93%) |
2.23 - 34.12 | 6,756,310 | 3,860,000 | 1,804,001 | ||
| 14-08-2023 | PM | BTAI | BioXcel Therapeutics, Inc. | 215.49 | -1.83 | -1.72 | -1.35 | BioXcel Therapeutics GAAP EPS of -$1.83 misses by $0.11, revenue of $0.46M misses by $0.01M [8/14/2023 7:05 AM] |
4.33 | -3.07 (-41.42%) |
4.95 | -2.45 (-33.11%) |
3.82 - 34.12 | 8,620,707 | 1,220,000 | 785,816 | ||
| 08-05-2023 | PM | 7:00 AM ET (May 8) |
BTAI | BioXcel Therapeutics, Inc. | 658.23 | -1.84 | -1.56 | -1.12 | BioXcel Therapeutics GAAP EPS of -$1.84 misses by $0.18, revenue of $0.21M misses by $0.11M [5/8/2023 7:02 AM] |
26.27 | 3.09 (13.36%) |
21.00 | -2.17 (-9.37%) |
8.80 - 34.12 | 769,754 | 400,000 | 44,498 | |
| 09-03-2023 | PM | 7:00 AM ET (Mar 9) |
BTAI | BioXcel Therapeutics, Inc. | 801.46 | -1.95 | -1.49 | -0.93 | BioXcel Therapeutics GAAP EPS of -$1.95 misses by $0.51, revenue of $0.24M misses by $0.84M [3/9/2023 7:03 AM] |
24.55 | -3.81 (-13.43%) |
26.00 | -2.36 (-8.32%) |
8.80 - 34.12 | 776,804 | 330,000 | 5,949 | |
| 10-11-2022 | PM | 7:00 AM ET (Nov 10) |
BTAI | BioXcel Therapeutics, Inc. | 343.28 | -1.49 | -1.34 | -0.96 | BioXcel Therapeutics GAAP EPS of -$1.49 misses by $0.15, revenue of $0.14M [11/10/2022 7:03 AM] |
14.72 | 3.31 (29.05%) |
11.10 | -0.31 (-2.72%) |
8.80 - 36.49 | 724,493 | 160,000 | 9,939 | |
| 09-08-2022 | PM | 7:00 AM ET (Aug 9) |
BTAI | BioXcel Therapeutics, Inc. | 443.56 | -1.35 | -1.20 | -1.11 | BioXcel Therapeutics GAAP EPS of -$1.35 misses by $0.12 [8/9/2022 7:05 AM] |
15.35 | -1.27 (-7.64%) |
16.52 | -0.10 (-0.60%) |
8.79 - 36.49 | 376,916 | 290,000 | 975 | |
| 09-05-2022 | PM | 7:00 AM ET (May 9) |
BTAI | BioXcel Therapeutics, Inc. | 383.61 | -1.12 | -1.21 | -1.08 | BioXcel Therapeutics GAAP EPS of -$1.12 beats by $0.01 [5/9/2022 7:10 AM] |
11.31 | -1.25 (-9.91%) |
12.50 | -0.06 (-0.47%) |
11.28 - 39.00 | 792,291 | 460,000 | 28,663 | |
|
||||||||||||||||||
| 10-03-2022 | PM | 7:00 AM ET (Mar 10) |
BTAI | BioXcel Therapeutics, Inc. | 498.89 | -0.93 | -1.18 | -0.87 | BioXcel Therapeutics GAAP EPS of -$0.93 beats by $0.21 [3/10/2022 7:08 AM] |
16.71 | -0.99 (0.00%) |
19.15 | 0.26 (1.38%) |
14.32 - 49.78 | 230,003 | 290,168 | 72,460 | |
|
||||||||||||||||||
| 10-11-2021 | PM | 7:00 AM ET (Nov 10) |
BTAI | BioXcel Therapeutics, Inc. | 957.66 | -0.96 | -1.08 | -1.07 | BioXcel Therapeutics EPS beats by $0.11 [11/10/2021 7:20 AM] |
34.20 | 0.33 (0.97%) |
33.87 | 0.0 (0.00%) |
23.07 - 67.74 | 231,068 | 200,000 | 250 | |
| 10-08-2021 | PM | 7:00 AM ET (Aug 10) |
BTAI | BioXcel Therapeutics, Inc. | 728.02 | -1.11 | -1.03 | -1.06 | BioXcel Therapeutics EPS misses by $0.03 [8/10/2021 7:03 AM] |
24.93 | -0.06 (-0.24%) |
25.00 | 0.01 (0.04%) |
23.79 - 67.74 | 310,751 | 280,000 | 1,068 | |
| 10-05-2021 | PM | 7:15 AM ET (May 10) |
BTAI | BioXcel Therapeutics, Inc. | 752.99 | -1.08 | -0.89 | -0.79 | BioXcel Therapeutics EPS misses by $0.14 [5/10/2021 7:12 AM] |
30.44 | -0.08 (-0.26%) |
30.52 | 0.0 (0.00%) |
29.50 - 71.50 | 404,937 | 310,000 | 4,960 | |
| 11-03-2021 | PM | 7:00 AM ET (Mar 11) |
BTAI | BioXcel Therapeutics, Inc. | 1,080 | -0.87 | -0.86 | -0.45 | BioXcel Therapeutics EPS beats by $0.07 [3/11/2021 7:18 AM] |
47.37 | 2.12 (4.69%) |
48.03 | 2.78 (6.14%) |
13.77 - 71.50 | 557,703 | 489,170 | 6,373 | |
|
||||||||||||||||||
| 12-11-2020 | PM | 7:00 AM ET (Nov 12) |
BTAI | BioXcel Therapeutics, Inc. | 1,230 | -1.07 | -0.80 | -0.57 | BioXcel Therapeutics EPS misses by $0.28 [11/12/2020 7:05 AM] |
55.21 | -1.37 (-2.42%) |
56.77 | 0.19 (0.34%) |
4.20 - 71.50 | 346,202 | 409,554 | 3,552 | |
|
|
||||||||||||||||||
| 14-08-2020 | PM | 7:00 AM ET (Aug 14) |
BTAI | BioXcel Therapeutics, Inc. | 1,050 | -1.06 | -0.74 | -0.54 | BioXcel Therapeutics EPS misses by $0.28 [8/14/2020 7:06 AM] |
39.94 | -4.77 (-10.67%) |
41.50 | -3.21 (-7.18%) |
3.76 - 71.50 | 1,349,823 | 676,972 | 63,935 | |
|
|
||||||||||||||||||
| 12-05-2020 | PM | 7:00 AM ET (May 12) |
BTAI | BioXcel Therapeutics, Inc. | 815.57 | -0.79 | -0.55 | -0.46 | BioXcel Therapeutics EPS misses by $0.21 [5/12/2020 7:02 AM] |
40.68 | -2.33 (-5.42%) |
40.68 | 0.0 (0.00%) |
3.76 - 44.41 | 454,838 | 468,661 | 959 | |
|
|
||||||||||||||||||